Cracking down on counterfeitingFORCINIO, Hallie.Pharmaceutical technology (2003). 2006, Vol 30, Num 8, issn 1543-2521, 46-49 [3 p.]Article

Custom synthesis and custom chemicalsPOLASTRO, Enrico T.Pharmaceutical technology (2003). 2006, Num outsou, issn 1543-2521, 42-66 [13 p.], SUPArticle

Global supply and procurement march onMILLER, Jim.Pharmaceutical technology (2003). 2006, Vol 30, Num 11, issn 1543-2521, 102-104 [2 p.]Article

How much longer will CROs find success in failure?MILLER, Jim.Pharmaceutical technology (2003). 2006, Vol 30, Num 9, pp 126-128, issn 1543-2521, 3 p.Article

In the loop : Continuous chromatography for chiral (and other) separationsMCCORMICK, Douglas.Pharmaceutical technology (2003). 2006, Vol 30, Num 5, issn 1543-2521, 54-68 [9 p.]Article

SOCMA launches ChemStewards program : New EHS&S program is underwayVAN ARNUM, Patricia.Pharmaceutical technology (2003). 2006, Vol 30, Num 2, issn 1543-2521, 50-54 [3 p.]Article

Optimization strategies for API synthesis and formulation developmentVAN ARNUM, Patricia.Pharmaceutical technology (2003). 2006, Vol 30, Num 11, issn 1543-2521, 44-54 [6 p.]Article

Oral insulin delivery strategies using : Absorption promoters, absorption enhancers, and protease inhibitorsKHAN GHILZAI, Naushad M.Pharmaceutical technology (2003). 2006, Vol 30, Num 4, issn 1543-2521, 88-98 [6 p.]Article

Out-of-specification results and the quality system approach to GMPsWISE-BLACKMAN, Gwendolyn M.Pharmaceutical technology (2003). 2006, Num CGMP, issn 1543-2521, S4-S10, SUPArticle

PQRI survey of pharmaceutical exdpient testing and control strategies : Used by excipient manufacturers, excipient distributors, and drug-product manufacturersLAMER, Gregory; SCHONEKER, David; SHEEHAN, Catherine et al.Pharmaceutical technology (2003). 2006, Vol 30, Num 9, pp 90-98, issn 1543-2521, 9 p.Article

Rising players in global fine chemicalsVAN ARNUM, Patricia.Pharmaceutical technology (2003). 2006, Vol 30, Num 7, pp 52-58, issn 1543-2521, 7 p.Article

The role of glasses in aseptic production : A detail often ignoredBATTISTINI, Maurizio.Pharmaceutical technology (2003). 2006, Vol 30, Num 10, issn 1543-2521, 136-140 [3 p.]Article

Outsourcing toolkits from the PharmTech annual eventRIOS, Maribel.Pharmaceutical technology (2003). 2006, Num outsou, issn 1543-2521, 68-70 [2 p.], SUPArticle

Analytical methods validation : In-process control methods for the manufacture of active pharmaceutical ingredientsZAYAS, Jose; SANCHEZ, Victor; TALLEY, Michelle et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 4, pp 154-162, issn 1543-2521, 5 p.Article

Bulk actives postapproval changes BACPAC II : PhRMA perspectives on the development of a new FDA guidanceCURRAN, John; MAVROUDAKIS, Wendy; RIDGE, Dave et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 11, pp 60-72, issn 1543-2521, 7 p.Article

Comparison of EP heavy Metals test with USP conductivity testTORRES, George; ARSITIO, Arlene; GENOVESI, Carole et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 1, pp 80-82, issn 1543-2521, 2 p.Article

FDA lowers barriers to process improvementBUSH, Laura.Pharmaceutical technology (2003). 2005, Vol 29, Num 10, pp 54-64, issn 1543-2521, 6 p.Article

Frequency modulation spectroscopy : A novel nondestructive approach for measuring moisture activity in pharmaceutical samplesMAHAJAN, Rajiv; TEMPLETON, Allen C; REED, Robert A et al.Pharmaceutical technology (2003). 2005, Vol 29, Num 10, pp 88-104, issn 1543-2521, 9 p.Article

Identifying marksFORCINIO, Hallie.Pharmaceutical technology (2003). 2005, Vol 29, Num 8, pp 34-35, issn 1543-2521, 2 p.Article

Optimism taking over in pharmaceutical chemicalsMILLER, Jim.Pharmaceutical technology (2003). 2005, Vol 29, Num 3, pp 104-106, issn 1543-2521, 2 p.Article

Pilots and partnerships move RFID forwardFORCINIO, Hallie.Pharmaceutical technology (2003). 2005, Vol 29, Num 9, pp 42-46, issn 1543-2521, 3 p.Article

Riding the waveMILLER, Jim.Pharmaceutical technology (2003). 2005, Vol 29, Num 8, pp 56-57, issn 1543-2521, 2 p.Article

Using visible residue limits for introducing new compounds into a pharmaceutical research facilityFORSYTH, Richard J; VAN NOSTRAND, Vincent.Pharmaceutical technology (2003). 2005, Vol 29, Num 4, pp 134-140, issn 1543-2521, 4 p.Article

FDA moves to streamline CMC review, promote drug qualityWECHSLER, Jill.Pharmaceutical technology (2003). 2005, Vol 29, Num 12, pp 36-42, issn 1543-2521, 6 p.Article

The eighth annual international employment surveyRIOS, Maribel.Pharmaceutical technology (2003). 2005, Vol 29, Num 12, pp 44-52, issn 1543-2521, 5 p.Article